Lactate/Hydroxycarboxylic Acid Receptor 1 in Alzheimer's Disease: Mechanisms and Therapeutic Implications-Exercise Perspective
- PMID: 38427215
- DOI: 10.1007/s12035-024-04067-x
Lactate/Hydroxycarboxylic Acid Receptor 1 in Alzheimer's Disease: Mechanisms and Therapeutic Implications-Exercise Perspective
Abstract
Lactate has a novel function different from previously known functions despite its traditional association with hypoxia in skeletal muscle. It plays various direct and indirect physiological functions. It is a vital energy source within the central nervous system (CNS) and a signal transmitter regulating crucial processes, such as angiogenesis and inflammation. Activating lactate and its associated receptors elicits effects like synaptic plasticity and angiogenesis alterations. These effects can significantly influence the astrocyte-neuron lactate shuttle, potentially impacting cognitive performance. Decreased cognitive function relates to different neurodegenerative conditions, including Alzheimer's disease (AD), ischemic brain injury, and frontotemporal dementia. Therefore, lactic acid has significant potential for treating neurodegenerative disorders. Exercise is a method that induces the production of lactic acid, which is similar to the effect of lactate injections. It is a harmless and natural way to achieve comparable results. Animal experiments demonstrate that high-intensity intermittent exercise can increase vascular endothelial growth factor (VEGF) levels, thus promoting angiogenesis. In vivo, lactate receptor-hydroxycarboxylic acid receptor 1 (HCAR1) activation can occur by various stimuli, including variations in ion concentrations, cyclic adenosine monophosphate (cAMP) level elevations, and fluctuations in the availability of energy substrates. While several articles have been published on the benefits of physical activity on developing Alzheimer's disease in the CNS, could lactic acid act as a bridge? Understanding how HCAR1 responds to these signals and initiates associated pathways remains incomplete. This review comprehensively analyzes lactate-induced signaling pathways, investigating their influence on neuroinflammation, neurodegeneration, and cognitive decline. Consequently, this study describes the unique role of lactate in the progression of Alzheimer's disease.
Keywords: Alzheimer’s disease; Cognitive function; Lactic acid; Neuroinflammation; Signal pathway.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
The lactate receptor, G-protein-coupled receptor 81/hydroxycarboxylic acid receptor 1: Expression and action in brain.J Neurosci Res. 2015 Jul;93(7):1045-55. doi: 10.1002/jnr.23593. Epub 2015 Apr 16. J Neurosci Res. 2015. PMID: 25881750 Review.
-
Exercise induces cerebral VEGF and angiogenesis via the lactate receptor HCAR1.Nat Commun. 2017 May 23;8:15557. doi: 10.1038/ncomms15557. Nat Commun. 2017. PMID: 28534495 Free PMC article.
-
Lactate links exercise to synaptic protection and cognitive enhancement in Alzheimer's disease models.BMC Med. 2025 Jun 3;23(1):331. doi: 10.1186/s12916-025-04168-x. BMC Med. 2025. PMID: 40462081 Free PMC article.
-
Modulation of the Astrocyte-Neuron Lactate Shuttle System contributes to Neuroprotective action of Fibroblast Growth Factor 21.Theranostics. 2020 Jul 9;10(18):8430-8445. doi: 10.7150/thno.44370. eCollection 2020. Theranostics. 2020. PMID: 32724479 Free PMC article.
-
Lactate transport and signaling in the brain: potential therapeutic targets and roles in body-brain interaction.J Cereb Blood Flow Metab. 2015 Feb;35(2):176-85. doi: 10.1038/jcbfm.2014.206. Epub 2014 Nov 26. J Cereb Blood Flow Metab. 2015. PMID: 25425080 Free PMC article. Review.
References
-
- Breijyeh Z, Karaman R (2020) Comprehensive review on Alzheimer’s disease: causes and treatment. Molecules 25(24). https://doi.org/10.3390/molecules25245789
-
- (2023) 2023 Alzheimer’s disease facts and figures. Alzheimers Dement 19(4):1598-1695. https://doi.org/10.1002/alz.13016
-
- Agüero P, Sainz MJ, Téllez R, Lorda I, Ávila A, García-Ribas G, Rodríguez PP, Gómez-Tortosa E (2021) De novo PS1 mutation (Pro436Gln) in a very early-onset posterior variant of Alzheimer’s disease associated with spasticity: a case report. J Alzheimers Dis 83(3):1011–1016. https://doi.org/10.3233/jad-210420 - DOI - PubMed
-
- Beeri MS, Leugrans SE, Delbono O, Bennett DA, Buchman AS (2021) Sarcopenia is associated with incident Alzheimer’s dementia, mild cognitive impairment, and cognitive decline. J Am Geriatr Soc 69(7):1826–1835. https://doi.org/10.1111/jgs.17206 - DOI - PubMed - PMC
-
- Boyle PA, Buchman AS, Wilson RS, Leurgans SE, Bennett DA (2009) Association of muscle strength with the risk of Alzheimer disease and the rate of cognitive decline in community-dwelling older persons. Arch Neurol 66(11):1339–1344. https://doi.org/10.1001/archneurol.2009.240 - DOI - PubMed - PMC
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical